Aspire Biopharma Holdings, Inc. Common Stock

ASBPNASDAQ • USD
ThemeNanotech & Adv. Materials›Nanomedicine & Drug Delivery
7.81 USD
↘ 0.16 (2.01%)AT CLOSE (11:59 AM EDT)
7.82
↗ 0.01 (0.08%)
POST MARKET (AS OF 07:32 PM EDT)
Post Market
AS OF 07:32 PM EDT
7.82
↗ 0.01 (0.08%)
🔴Market: CLOSED

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is currently trading at $7.97. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. ASBP is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Aug 24, 2026.

Open?$7.79
High?$8.21
Low?$7.79
Prev. Close?$7.97
Volume?43.8K
Avg. Volume?42.3K
VWAP?$7.99
Rel. Volume?1.03x
Bid / Ask
Bid?$7.60 × 100
Ask?$8.50 × 400
Spread?$0.90
Midpoint?$8.05
Valuation & Ratios
Market Cap?11.0M
Shares Out?1.4M
Float?1.0M
Float %?78.9%
P/E Ratio?N/A
P/B Ratio?0.93
EPS?-$7.88
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
Themes
Nanotechnology & Advanced Materials›Nanomedicine & Drug DeliveryBiotech - Drug Development›Clinical-Stage Platforms
Employees
N/A
Market Cap
11.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.aspirebiolabs.com
Listed
2025-02-20
Address
23150 FASHION DRIVE, SUITE 232
ESTERO, FL 33928
Phone: 561-704-8527
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
2
Momentum?
90
Short Sent.?
83
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.33Distress
Confidence?36%Very Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?7.82%Elevated
Short Interest?79.9K
Days to Cover?1.5
Free Float1.0M
Avg Daily Volume54.6K
Settlement Date2026-07-31
Financial Health
Current Ratio?7.99Strong
Quick Ratio?7.81Strong
Cash Ratio?7.22Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.93CHEAP▾
P/S?
Peers
100
S&P
3
112.17HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.2CHEAP▾
EV/Sales?
S&P
97
-12.42CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-94.0%WEAK▾
ROA?
S&P
3
-81.6%WEAK▾
Cash Flow & Enterprise
FCF?$-7185846
Enterprise Value?$-1213166
Fundamentals ratios updated end of day
MarketsMoversWatchlist